Literature DB >> 29658088

Pathogenetic Role of Endothelial Dysfunction in Idiopathic Vestibulopathy.

E V Udut1,2, P P Shchetinin3, T V Rudenko3, F Lucieer4, H Kingma3,4, A P Shchetinina3, M O Pleshkov3, V P Demkin3, V V Udut3,5.   

Abstract

Comparative analysis of the groups of patients with idiopathic bilateral vestibular hypofunction and a group of vestibulopathy patients with vertebrobasilar insufficiency demonstrated identity of the basic and additional diagnostic parameters in these syndromes as well as similarity in clinical diagnostic and anamnesis data. In all cases, functional assessment of endothelium-dependent vasodilation and selected biochemical marker sICAM-1 revealed endothelial dysfunction. Drug correction of endothelial dysfunction positively affected the manifestations of major and minor features of the syndrome, which confirmed the contribution of endothelial functional disturbances to the pathogenesis of bilateral vestibular hypofunction.

Entities:  

Keywords:  bilateral vestibular hypofunction; endothelial dysfunction; etiology; vertigo; vestibular tests

Mesh:

Substances:

Year:  2018        PMID: 29658088     DOI: 10.1007/s10517-018-4067-0

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  Electrophysiological and inner ear MRI findings in patients with bilateral vestibulopathy.

Authors:  Michael Eliezer; Charlotte Hautefort; Christian Van Nechel; Ulla Duquesne; Jean-Pierre Guichard; Philippe Herman; Romain Kania; Emmanuel Houdart; Arnaud Attyé; Michel Toupet
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-08       Impact factor: 2.503

2.  IGST Combined with Conventional Drug Therapy and TCM Therapy for Treatment of Bilateral Vestibular Hypofunction.

Authors:  Mingming Zhao; Jing Han; Liang Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-07       Impact factor: 2.650

Review 3.  Recent advances in idiopathic bilateral vestibulopathy: a literature review.

Authors:  Chisato Fujimoto; Masato Yagi; Toshihisa Murofushi
Journal:  Orphanet J Rare Dis       Date:  2019-08-19       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.